Skip to search formSkip to main contentSkip to account menu

Sumatriptan

Known as: 1-[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]-N-methyl-methanesulfonamide, Sumatriptán, 3-(2-(Dimethylamino)ethyl)-N-methyl-1H-indole-5-methanesulfonamide 
A sulfonamide triptan with vasoconstrictor activity. Sumatriptan selectively binds to and activates serotonin 5-HT1D receptors in the central nervous… 
National Institutes of Health

Related topics

Related topics

43 relations
0.5 ML Sumatriptan 12 MG/ML Cartridge0.5 ML Sumatriptan 12 MG/ML Cartridge [Imitrex]0.5 ML Sumatriptan 12 MG/ML Jet Injector [Sumavel]0.5 ML Sumatriptan 12 MG/ML Prefilled Syringe

Narrower (10)

AlsumaCP 122288CP 122638GR-43175

Broader (5)

Serotonin 5-HT1 Receptor AgonistsSulfonamidesTriptansVasoconstrictor Agents

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Medication Overuse Headache from Antimigraine Therapy
Medication overuse headache (MOH) is being recognised more often in headache, neurology and primary care clinics, but is still… 
2010
2010
UV-SPECTROSCOPIC METHODS FOR ESTIMATION OF RIZATRIPTAN BENZOATE IN PHARMACEUTICAL PREPARATIONS
Rizatriptan benzoate is a triptan drug and it is a selective 5-Hydroxy Triptamine1B/1D (5-HT 1B/1D) receptor agonist, used as an… 
Review
2008
Review
2008
Early Treatment in Migraine: How Strong is the Current Evidence?
Over the last 10 years, triptans (serotonin 5-HT1B/1D receptor agonists) have proved to be efficacious in treating migraine pain… 
2006
2006
Influence of delaying gastric emptying on meal‐related symptoms in healthy subjects
Background  Although delayed gastric emptying is often found in functional dyspepsia, a causal role for delayed emptying in… 
Review
2006
Review
2006
Topiramate Prophylaxis and Response to Triptan Treatment for Acute Migraine
Objective.—To evaluate the effect of topiramate migraine prophylaxis on subject responsiveness to triptans used for acute… 
2005
2005
Triptans for Migraine Therapy: A Comparison Based on Number Needed to Treat and Doses Needed to Treat
OBJECTIVES: Managed care and other decision makers need sound comparative information to support the formulary selection process… 
2004
2004
A revised classification of headache disorders
Regular updates are still necessary For many years the classification of headache syndromes, and particularly of those… 
1997
1997
Comparison of the cardiovascular effects of the novel 5-HT(1B/1D) receptor agonist, SB 209509 (VML251), and sumatriptan in dogs.
The systemic cardiovascular effects of a novel 5-hydroxtryptamine (5-HT)(1B/1D)-receptor agonist were investigated in the… 
1995
1995
Patient preferences for migraine therapy: subcutaneous sumatriptan compared with other medications.
BACKGROUND: This study was conducted to identify, from the patient's perspective, the important attributes of a migraine therapy… 
1965
1965
Migraine in children.
In man, also, mycoplasmas occur in the respiratory and genital tracts. However, Mycoplasma pneumoniae, which causes cold… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)